UPDATED May 29, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PRPH | US$4.98 | -6.6% | -45.6% | US$98.3m | US$18.50 | PS3.3x | E97.4% | 0% | Pharmaceuticals & Biotech | ||
TOST | US$23.61 | -7.0% | 9.4% | US$13.1b | US$27.44 | PS3.2x | E63.4% | n/a | Diversified Financials | ||
ALAB | US$65.53 | -6.5% | n/a | US$10.5b | US$87.73 | PS62.4x | E62.8% | n/a | Semiconductors | ||
NXGL | US$2.06 | -10.4% | -14.2% | US$13.1m | US$6.00 | PS2.7x | E67.5% | n/a | Healthcare | ||
ASTH | US$40.06 | 6.3% | 24.1% | US$1.9b | US$54.17 | PE31.4x | E24.9% | n/a | Healthcare | ||
APP | US$82.50 | 4.1% | 232.3% | US$27.6b | US$93.24 | PE45.7x | E24.7% | n/a | Software | ||
ACER | US$0.80 | -5.4% | -30.0% | US$19.7m | n/a | PE-0.5x | E66.2% | n/a | Pharmaceuticals & Biotech | ||
IOVA | US$9.28 | -10.2% | 6.2% | US$2.7b | US$25.92 | PS1363.9x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
ULCC | US$5.22 | -7.0% | -36.9% | US$1.2b | US$7.50 | PB2.4x | E72.3% | 0% | Transportation | ||
KRYS | US$161.54 | -1.3% | 38.3% | US$4.5b | US$189.00 | PE80.7x | E38.4% | n/a | Pharmaceuticals & Biotech | ||
LQDA | US$12.86 | 0.2% | 49.0% | US$948.7m | US$24.14 | PS61.5x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
UNCY | US$0.84 | -13.6% | -39.8% | US$31.6m | US$5.30 | PE-0.8x | E51.1% | n/a | Pharmaceuticals & Biotech | ||
MNDY | US$224.40 | -8.3% | 23.4% | US$11.8b | US$259.67 | PE552.6x | E35.0% | n/a | Software | ||
FLUX | US$3.10 | -1.0% | -12.2% | US$50.0m | US$9.00 | PB9.5x | E63.6% | n/a | Capital Goods | ||
QSG | US$2.62 | 16.4% | -69.5% | US$144.0m | US$7.52 | PE5.3x | E43.4% | n/a | Consumer Services | ||
CONN | US$3.18 | -11.4% | -23.0% | US$81.1m | US$5.50 | PB0.2x | E90.8% | n/a | Retail | ||
BCAL | US$13.92 | -1.7% | 1.6% | US$257.6m | US$18.25 | PB0.9x | E70.9% | n/a | Banks | ||
CCB | US$43.69 | 0.7% | 24.1% | US$577.7m | US$54.50 | PB1.9x | E43.2% | n/a | Banks | ||
ECOR | US$6.57 | -4.9% | 36.2% | US$39.1m | US$23.16 | PS2.1x | E69.5% | n/a | Healthcare | ||
EVAX | US$3.68 | -5.2% | -75.3% | US$19.4m | US$11.75 | PS160.6x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
DUOL | US$194.44 | 10.6% | 26.1% | US$8.5b | US$253.60 | PE183.9x | E46.4% | n/a | Consumer Services | ||
YTRA | US$1.61 | 5.2% | -24.1% | US$97.5m | US$4.00 | PS1.9x | E207.1% | n/a | Consumer Services | ||
MCBI | US$17.45 | -0.3% | 9.1% | US$111.2m | US$21.00 | PB0.9x | E58.6% | 1.8% | Banks | ||
LGIH | US$95.50 | 0.9% | -16.8% | US$2.2b | US$109.67 | PE11.9x | E24.0% | n/a | Consumer Durables |